4//SEC Filing
HAVEL JAMES M 4
Accession 0000950138-18-000679
CIK 0001532063other
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 4:38 PM ET
Size
8.3 KB
Accession
0000950138-18-000679
Insider Transaction Report
Form 4
HAVEL JAMES M
Exec. VP and Interim CFO
Transactions
- Disposition to Issuer
Common Stock
2018-12-20−57,833→ 0 total - Disposition to Issuer
Phantom Stock Units
2018-12-20−23.823→ 0 totalExercise: $0.00→ Express Scripts Holding Company Common Stock (23.823 underlying)
Footnotes (5)
- [F1]Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Cigna Corporation, Halfmoon Parent, Inc., Halfmoon I, Inc. and Halfmoon II, Inc., upon closing of the merger of Halfmoon II, Inc. with and into the Issuer (the "Merger"), each common share of the Issuer was converted into the right to receive 0.2434 shares of Halfmoon Parent, Inc. common stock and $48.75 in cash. Each restricted stock unit was converted into a unit with respect to common stock of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement.
- [F2]Phantom Stock Unit credited under the Company's Executive Deferred Compensation Plan.
- [F3]Upon distribution, each phantom stock unit would have converted into one share of the Issuer's common stock.
- [F4]Pursuant to the Merger Agreement, upon closing of the Merger, each phantom stock unit was converted into a stock unit relating to the common stock of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement.
- [F5]Basic Company Credit by the Issuer to Reporting Person's Account in the Executive Deferred Compensation Plan; shares vest 3 (three) years after the plan year to which such credit relates.
Documents
Issuer
Express Scripts Holding Co.
CIK 0001532063
Entity typeother
Related Parties
1- filerCIK 0001602629
Filing Metadata
- Form type
- 4
- Filed
- Dec 20, 7:00 PM ET
- Accepted
- Dec 21, 4:38 PM ET
- Size
- 8.3 KB